Garwood Medical Device contracts with UB institute; pledges to create 40 jobs

Buffalo Business First I Dan Miner

Garwood Medical Devices expects to create 40 new jobs in Buffalo over the next five years after signing a $1.48 million agreement with the University at Buffalo’s Buffalo Institute for Genomics and Data Analytics.

That institute – which uses the acronym BIG – represents UB’s side of a partnership with the New York Genome Center in Manhattan. It is backed by $100 million in state funding which aims to support high-speed analysis of genomic data for use by university researchers and private companies. The data, supplied by the New York Genome Center, will be crunched at UB supercomputers at its Center for Computational Research.

Garwood Medical was recently named a semifinalist in the 43North competition and is a member of the Start-Up NY tax breaks program. It is a medical device company that is developing a new class of programmable electrical stimulation devices which show potential for the chronic wound healing, bone growth and peri-prosthetic infections, according to a UB news release.

Garwood will move into UB’s downtown Gateway Building this summer. It is run by Wayne Bacon, who is its chair and CEO.

BIG will provide $1.48 million in technology and resource support to the company.

Original article can be found here.